Injective INJ
Current Price
$4.36 -3.86%
$0.3300 Daily Range (7.57%)
$4.21$4.54
$42.54M Daily Volume
486 BTC
Vol/MktCap: 9.76%
Market Performance
0.09% Relative BTC Volume
The total volume of Injective is $42.54M over the past 24 hours, compared to $44.89B total Bitcoin volume.
Hourly Moving Average
8 SMA $4.28 +1.83%
13 SMA $4.35 +0.17%
21 SMA $4.40 -1.02%
55 SMA $4.50 -3.15%
144 SMA $4.58 -4.89%
Price Performance
+1.74% 1 Hour Change
$4.36 from $4.29
-6.29% 7 Day Change
-$0.2741 from $4.63
-16.29% 14 Day Change
-$0.7101 from $5.07
-6.02% 30 Day Change
-$0.2626 from $4.62
All Time High
March 14, 2024
$52.62 -91.72%
-$48.26 vs. now
24H Change
-17.40M USD -3.84%
-199 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
9.72M INJ
traded over past 24 hours
9.72% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $4.28, reflecting a 24-hour change of -5.35%. The daily range shows the price fluctuated between $4.21 and $4.56, indicating a relatively tight trading band of 0.35% within this period.
The volume of 40,290,731 represents 9.40% of the market cap, suggesting a moderate level of trading activity. However, the RSI values indicate bearish momentum, with the 1-hour RSI at 23 (oversold) and the 7-day RSI at 43 (approaching oversold), highlighting weak buying pressure.
Short-term moving averages are also signaling downward momentum, with the 8 SMA at $4.28 just slightly above the current price and the 144 SMA at $4.58 reflecting a more considerable decline of -6.63%. The 7-day price change is a significant -17.90%, and the 14-day change stands at -16.53%, confirming a prevailing negative trend over both short and medium terms.
Fundamentally, the recent downward price action coupled with high volume and low RSI levels suggest a lack of investor confidence. This is further compounded by the stark contrast to the all-time high of $52.62 from March 2024, indicating substantial market correction and loss of value since that peak.
In summary, the current technical indicators combined with the bearish price movements point towards a continued downtrend. Given these factors, the recommendation for Injective (INJ) is a Sell rating, as further declines are likely until stronger bullish indicators emerge.
The volume of 40,290,731 represents 9.40% of the market cap, suggesting a moderate level of trading activity. However, the RSI values indicate bearish momentum, with the 1-hour RSI at 23 (oversold) and the 7-day RSI at 43 (approaching oversold), highlighting weak buying pressure.
Short-term moving averages are also signaling downward momentum, with the 8 SMA at $4.28 just slightly above the current price and the 144 SMA at $4.58 reflecting a more considerable decline of -6.63%. The 7-day price change is a significant -17.90%, and the 14-day change stands at -16.53%, confirming a prevailing negative trend over both short and medium terms.
Fundamentally, the recent downward price action coupled with high volume and low RSI levels suggest a lack of investor confidence. This is further compounded by the stark contrast to the all-time high of $52.62 from March 2024, indicating substantial market correction and loss of value since that peak.
In summary, the current technical indicators combined with the bearish price movements point towards a continued downtrend. Given these factors, the recommendation for Injective (INJ) is a Sell rating, as further declines are likely until stronger bullish indicators emerge.
Updated 88 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Russia Targets Crypto’s Shadow War Pipeline as WhiteBit Faces Sweeping Ban
Russia’s Prosecutor General has designated Ukrainian cryptocurrency exchange WhiteBit as an “undesirable organization.” They accuse it of facilitating illegal…

Entropy, a16z-backed decentralized custody startup, is winding down and returning capital to investors
Entropy's "anti-capitalist anarchist" founder is winding down the firm and returning capital to investors after failing to find a scalable business model.

67% of Binance traders are long on Chainlink – Is LINK ready to reclaim $14.15?
Binance traders are heavily long on LINK, but price structure suggests the next move isn’t settled yet.

Digitap ($TAP) the Best Crypto to Buy Under Trump’s New Crypto Bill
President Donald Trump appeared at the World Economic Forum in Davos.